HK1007961A1 - Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging - Google Patents

Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging

Info

Publication number
HK1007961A1
HK1007961A1 HK98107202A HK98107202A HK1007961A1 HK 1007961 A1 HK1007961 A1 HK 1007961A1 HK 98107202 A HK98107202 A HK 98107202A HK 98107202 A HK98107202 A HK 98107202A HK 1007961 A1 HK1007961 A1 HK 1007961A1
Authority
HK
Hong Kong
Prior art keywords
melatonin
production
pharmaceutical compositions
counteract
aging
Prior art date
Application number
HK98107202A
Other languages
English (en)
Inventor
Walter Pierpaoli
Giorgio Maestroni
Original Assignee
Cell Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Eng Ag filed Critical Cell Eng Ag
Publication of HK1007961A1 publication Critical patent/HK1007961A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
HK98107202A 1987-11-19 1998-06-27 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging HK1007961A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727099A GB8727099D0 (en) 1987-11-19 1987-11-19 Compositions containing melantonin/homologues
PCT/EP1988/001059 WO1989004659A1 (en) 1987-11-19 1988-11-21 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging

Publications (1)

Publication Number Publication Date
HK1007961A1 true HK1007961A1 (en) 1999-04-30

Family

ID=10627216

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98107202A HK1007961A1 (en) 1987-11-19 1998-06-27 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging

Country Status (7)

Country Link
EP (1) EP0343223B1 (xx)
JP (1) JP2568286B2 (xx)
AT (1) ATE91078T1 (xx)
DE (1) DE3882135T2 (xx)
GB (1) GB8727099D0 (xx)
HK (1) HK1007961A1 (xx)
WO (1) WO1989004659A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤
GB9000939D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa Improvement in the total synthesis of erbstatin analogs
GB9000950D0 (en) * 1990-01-16 1990-03-14 Erba Carlo Spa New arylvinylamide derivatives and process for their preparation
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
DE69229490T2 (de) * 1991-05-09 2000-02-17 Neurim Pharma 1991 Melatonin enthaltende Arzneimittel
JPH07503232A (ja) * 1991-10-18 1995-04-06 アルザ・コーポレーション メラトニンの制御経皮投与
SG41955A1 (en) * 1992-04-07 1997-08-15 Neurim Pharma 1991 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia
FR2741802B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine pour traiter les peaux sensibles
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
WO1998005298A1 (es) * 1996-08-02 1998-02-12 Universidad De Granada Desarrollo de productos cosmeticos para uso humano a base de melatonina como producto activo
FR2753095B1 (fr) * 1996-09-06 1998-11-20 Oreal Utilisation de la melatonine comme agent anti-inflammatoire dans une composition cosmetique ou pharmaceutique
US5880116A (en) * 1996-12-13 1999-03-09 Neurocal International Use of celastrol to treat alzheimer's disease
AU6385200A (en) * 1999-07-30 2001-02-19 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
PL1667678T3 (pl) 2003-10-03 2009-10-30 Veijlen N V Mieszanka paszowa dla zwierząt
DK1670444T3 (da) 2003-10-03 2011-08-22 Veijlen N V Anvendelse af IFG-1-serumniveau forhøjende indoleddikesyrederivater til fremstilling af en lægemiddelsammensætning til behandling af forskellige sygdomme
CN105637243B (zh) 2013-11-01 2017-12-15 世嘉智尼工业株式会社 合叶装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642994A (en) * 1970-05-25 1972-02-15 Fernando Anton T Therapeutic process using melatonin
DE2435365A1 (de) * 1973-12-31 1976-01-29 Luigi Di Bella Pharmazeutisches mittel fuer die behandlung von allen leukaemieformen und neurotischen syndromen
WO1986005093A2 (en) * 1985-03-04 1986-09-12 Cellena (Cell Engineering) A.G. Melatonin compositions and uses thereof

Also Published As

Publication number Publication date
JPH02502020A (ja) 1990-07-05
GB8727099D0 (en) 1987-12-23
WO1989004659A1 (en) 1989-06-01
DE3882135T2 (de) 1993-11-11
JP2568286B2 (ja) 1996-12-25
ATE91078T1 (de) 1993-07-15
EP0343223B1 (en) 1993-06-30
EP0343223A1 (en) 1989-11-29
DE3882135D1 (de) 1993-08-05

Similar Documents

Publication Publication Date Title
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
HK1007961A1 (en) Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
AU557590B2 (en) Aroylimidazolones
IL72928A0 (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
DK159088D0 (da) Overfladebehandlingskompostition
IL70269A (en) Composition for the treatment of arthritis comprising an azagermaspirodecane derivative
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IL89901A (en) Strobilurine derivative
AU1541088A (en) Composition for the treatment of the epiderm
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
DE3879709D1 (de) Platin-arzneimittel.
DE3368889D1 (en) Pesticide compositions for the treatment of wood
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
GB8703235D0 (en) Compositions for treatment of cellulosic materials

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041121